Newsroom

April 2016

• 
  Story Apr 25, 2016 Discovery

  Talking to: Bruno Strigini on why we're entering a transformative time in cancer care

  Accelerating Research to Get Answers Faster

• Press release Apr 21, 2016

  Novartis a enregistré un premier trimestre solide, malgré la perte d'exclusivité de Gleevec, et investi dans de nouveaux lancements pour soutenir la croissance à long terme

  Chiffre d'affaires net en hausse de 1% (tcc[1]), les produits de croissance ayant compensé l'impact du générique de Gleevec Les produits de croissance[2] ont progressé de 24% (en USD) à USD 3,9…
• Press release Apr 21, 2016

  Novartis delivered solid Q1 despite Gleevec loss of exclusivity; investing behind new launches for long-term growth

  Net sales up 1% (cc[1]), as Growth Products offset Gleevec impact Growth Products[2] grew 24% (USD) to USD 3.9 billion, or 34% of Group net sales Cosentyx (USD 176 million) continues to grow…
• Press release Apr 21, 2016

  Novartis erzielt im ersten Quartal trotz Verlust der Exklusivrechte an Gleevec solide Ergebnisse und investiert in Neueinführungen zugunsten langfristigen Wachstums

  Der Nettoumsatz steigt um 1% (kWk[1]), da die Wachstumsprodukte die Einbussen bei Gleevec kompensieren Die Wachstumsprodukte[2] steigern den Umsatz um 24% (USD) auf USD 3,9 Milliarden bzw. 34%…
• Press release Apr 20, 2016

  Novartis drug Afinitor® significantly reduces seizures in Phase III study of patients with tuberous sclerosis complex

  Everolimus is the first adjunctive therapy shown in a prospective randomized Phase III study to achieve clinically significant seizure control in TSC patients[1]   Seizures are the most…
• 
  Story Apr 18, 2016 Discovery

  Factory foreman keeps liver’s line workers on task

  A complex protein module keeps the liver’s biochemical factory running smoothly and at capacity.

• 
  Story Apr 14, 2016 Discovery

  How scientists aim to expand immunotherapy options for cancer patients

  Read how NIBR and Dana-Farber scientists aim to expand immunotherapy options for patients

• 
  Story Apr 13, 2016 Access to Healthcare

  A life dedicated to fighting malaria

  Lake Victoria in southwestern Kenya is on the front line in the fight against malaria, and Agnes Akoth is a key figure.

• In The News Apr 08, 2016

  Beautiful Medicine: Rediscover the Power of Nature’s Exquisite Complexity

• Press release Apr 08, 2016

  Sandoz receives EC approval for subcutaneous route of administration in biosimilar Binocrit's® nephrology indication

  Sandoz' epoetin alfa product offering has already generated more than 400,000[1] patient years of experience worldwide EC approval expands Sandoz biosimilar offering to the healthcare community…
• Press release Apr 07, 2016

  Novartis receives EU approval for Revolade® as first-in-class therapy for children aged 1 year and above with chronic ITP

  EU approval of Revolade expands treatment options for pediatric patients aged 1 year and above with chronic ITP who have not responded to other therapies Two formulations approved: once-daily…
• Featured News Apr 06, 2016

  Novartis and Red Cross partner to tackle chronic diseases in refugee populations

  Novartis is partnering with the International Committee of the Red Cross (ICRC) to improve care and treatment for Syrian refugees in Lebanon suffering from chronic diseases.